ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SMTI vs ZJYL // FREE CASH FLOW YIELD

Sanara MedTech Inc. (NASDAQ) VS. JIN MEDICAL INTERNATIONAL LTD. (Class A) (NASDAQ) • 15-METRIC TALLY: SMTI 8 — ZJYL 1
▲ FREE CASH FLOW YIELD LEADER: SMTI
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SMTI VS. ZJYL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SMTI ZJYL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 92.70% 29.20% +63.50 SMTI /gross-margins <GO>
Return on Invested Capital (ROIC) 16.30% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation 29.5x 47.1x -17.60 SMTI /valuation <GO>
Free Cash Flow Yield ACTIVE 0.71% -1.27% +1.98 SMTI /fcf-yield <GO>
Operating Margin 7.10% 2.90% +4.20 SMTI /operating-margins <GO>
Net Profit Margin 36.40% 5.80% +30.60 SMTI /net-margins <GO>
Revenue Growth (YoY) 19.00% -12.00% +31.00 SMTI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.25 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 4/9 +3.00 SMTI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 30.4 44.3 -13.90 ZJYL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 6.8x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $302.4M $294.2M $8.2M SMTI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SMTI REV ZJYL REV SMTI GROSS % ZJYL GROSS % SMTI FCF ZJYL FCF
FY 2025 $103.1M $20.7M 92.7% 29.2% $2.2M -$3.7M
FY 2024 $86.7M $23.5M 90.6% 40.4% -$229.6K -$1.4M
FY 2023 $65.0M $19.8M — — -$3.2M $3.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SMTI // BETA —
ZJYL // BETA —